Budget vs premium
Embody vs Novi: Which Costs Less Over 12 Months? (2026)
Compare Embody and Novi on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the Embody versus Novi question.
Novi costs 93% more per month than Embody once promotional pricing is out of the picture ($133/mo against $69/mo). Over a year that gap compounds into real money, and the question is what it buys.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Where a figure is not published, that is stated rather than estimated.
The short answer
- Lowest 12-month cost
- Embody — $828 against $1,596 at Novi, on each provider's own best published pricing.
- Most support for the money
- Novi — No long-term contract, cancel anytime.
- Quickest to start
- Novi — Online intake, then free 2-day shipping with every order.
- Most support included
- Novi — No long-term contract, cancel anytime.
Embody and Novi, side by side
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Embody | Novi | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | $69/mo | $133/mo |
| Pricing structure | Published rate per medication | Published rate per medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| State coverage | Not published | Not published |
| How fast you start | Licensed provider review handled entirely online | Online intake |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 11,250 | 50,124 |
| eRxDoctor score | 7.6/10 | 7.0/10 |
What you will have spent by month twelve
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. So the table works in the timeframe treatment actually happens in.
| Embody | Novi | |
|---|---|---|
| First month | $69 | $133 |
| Months 2 onward | $69/mo | $133/mo |
| 6-month total | $414 | $798 |
| 12-month total | $828 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Over a year that is a $768 difference, in Embody's favor. Whether it is the right call depends on whether Novi gives you $64 a month of something you will use.
What the price difference actually buys
Before treating the cheaper option as the obvious one, it is worth naming what the more expensive one includes — at Novi that is no long-term contract, cancel anytime, plus free 2-day shipping with every order.
Embody's answer is the lowest published semaglutide price on this list, with no lock-in. What it does not carry: a limited-time rate with few of the extras that higher-priced platforms bundle.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
Inside the Embody program
Semaglutide $69/mo (was $299), Tirzepatide $119/mo In this pairing, its distinguishing feature is the lowest published semaglutide price on this list, with no lock-in.
The process is licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. On money, expect published rate per medication — published upfront.
What continues after the first shipment: 24/7 support for dosing and side-effect questions. Formulary: compounded semaglutide and compounded tirzepatide.
Embody pros
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
Embody cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Final pricing may vary based on dose and clinician recommendation
The cost of choosing this over Novi: a limited-time rate with few of the extras that higher-priced platforms bundle.
A closer look at Novi
The pitch is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. $200 OFF - GLP-1 for $133 Today
Getting started means online intake, after which free 2-day shipping with every order. Pricing runs on a published rate per medication basis, published upfront.
No long-term contract, cancel anytime. The formulary covers compounded semaglutide and compounded tirzepatide.
Novi pros
- No insurance required and no long-term contract, cancel anytime
- $200 off promotion brings GLP-1 to $133 today
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
Novi cons
- Tirzepatide ($166) costs more than the semaglutide entry rate
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- No published outcome or weight loss guarantee
Against Embody specifically, the trade you are making: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Which one fits which patient
Choose Embody if:
- the twelve-month total is what you are optimizing ($828 against $1,596)
- the monthly rate is the constraint — $69/mo against $133/mo
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
- the feature you would actually use: the lowest published semaglutide price on this list, with no lock-in
Choose Novi if:
- delivery works the way you want it to: free 2-day shipping with every order
- you would get real value from the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
- you would rather use the platform with the longer public record (50,124 reviews)
- you want to start on their timeline: online intake
Where each program concedes something
On price. The monthly gap is 93% in Embody's favor. Whether that is a saving or a false economy turns on one thing: a limited-time rate with few of the extras that higher-priced platforms bundle.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On predictability. The pricing structures differ (published rate per medication versus published rate per medication), and structure, not headline rate, determines the twelve-month bill.
On access. Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval; Novi advertises online intake and free 2-day shipping with every order. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
What the evidence actually says
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The FDA approved tirzepatide for chronic weight management in November 2023, two years after semaglutide, per FDA.
In the STEP 1 trial, weekly semaglutide 2.4 mg produced a mean body-weight change of −14.9% at 68 weeks against −2.4% on placebo, per NEJM, STEP 1.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Embody vs Novi: common questions
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which costs less over a year, Embody or Novi?
Embody, at roughly $828 for twelve months against $1,596 at Novi, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Embody cheaper than Novi?
Yes, on the ongoing rate. Embody runs $69/mo once promotional pricing ends, against $133/mo at Novi — a difference of 93%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which has more patient reviews, Embody or Novi?
Novi, with 50,124 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Can I switch from Embody to Novi later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
The verdict
On the numbers, Embody wins the year: $828 against $1,596. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where Novi justifies itself is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. Where it does not is anywhere the extra spend buys features you will never open.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Wellmedr vs EmbodyTirzepatide access
- MedVi vs EmbodyBudget vs premium
- Novi vs TMatesTirzepatide access
- Novi vs Elevate HealthSame price, different service model
- Yucca Health vs JoinFridaysBudget vs premium
- Yucca Health vs MedViBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Novi, and does not sell treatment. Read our ranking methodology.